These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13240691)

  • 1. Effect of the source of the mouse mammary tumor agent (MTA) upon neutralization of the agent with antisera.
    BITTNER JJ; IMAGAWA DT
    Cancer Res; 1955 Aug; 15(7):464-8. PubMed ID: 13240691
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralization of the mouse mammary tumor virus by rabbit antisera against C3Hf tissue.
    BLAIR PB
    Cancer Res; 1963 Mar; 23():381-4. PubMed ID: 13971455
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mouse mammary tumor agent; the neutralization of the agent by placenta.
    HUMMEL KP; LITTLE CC; EDDY MS
    Cancer Res; 1949 Mar; 9(3):135. PubMed ID: 18113446
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mouse mammary tumor agent; survival and propagation of the agent in transplanted tumors and in hosts that grew these tumors in their tissues.
    HUMMEL KP; LITTLE CC
    Cancer Res; 1949 Mar; 9(3):137. PubMed ID: 18113447
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mouse mammary tumor agent; the agent in blood and other tissues in relation to the physiologic or endocrine state of the donor.
    HUMMEL KP; LITTLE CC
    Cancer Res; 1949 Mar; 9(3):129-34. PubMed ID: 18113445
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the mammary tumor agent on species other than the mouse.
    AMBRUS CM; HARRISON JW
    Experientia; 1952 Dec; 8(12):469. PubMed ID: 13021143
    [No Abstract]   [Full Text] [Related]  

  • 7. The distribution of the mammary tumor-inducing agent in the various constituents of the cytoplasm of mammary tumor cells in mice.
    DMOCHOWSKI L; HAAGENSEN CD
    Acta Unio Int Contra Cancrum; 1955; 11(6):646-53. PubMed ID: 13326667
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of physical and biological properties of mouse mammary tumor agent.
    MOORE DH; LASFARGUES EY; MURRAY MR; HAAGENSEN CD; POLLARD EC
    Acta Unio Int Contra Cancrum; 1959; 15():819-25. PubMed ID: 14423834
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammary cancer in mice of different ages and stocks following the administration of the mammary tumor agent.
    BITTNER JJ
    Cancer Res; 1956 Dec; 16(11):1038-42. PubMed ID: 13383470
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor-inducing properties of the mammary tumor agent in young and adult mice.
    BITTNER JJ
    Cancer Res; 1952 Jul; 12(7):510-5. PubMed ID: 14936024
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of low temperatures on mammary carcinomas with and without the mammary tumor milk agent.
    LAW LW
    Cancer Res; 1951 Oct; 11(10):795-800. PubMed ID: 14870152
    [No Abstract]   [Full Text] [Related]  

  • 12. The transplantability of mammary cancer in mice associated with the source of the mammary tumor milk agent.
    BITTNER JJ
    Cancer Res; 1947 Dec; 7(12):741-5. PubMed ID: 18880689
    [No Abstract]   [Full Text] [Related]  

  • 13. The mammary tumor agent in extracts of frozen and unfrozen mammary cancers.
    BITTNER JJ; IMAGAWA DT
    Cancer Res; 1953 Jul; 13(7:1):525-8. PubMed ID: 13067070
    [No Abstract]   [Full Text] [Related]  

  • 14. Host-induced changes in the mouse mammary tumor agent from transplanted tumors as determined by neutralization studies.
    BITTNER JJ; HIRSCH HM; ROSS JD; GABRIELSON R
    Cancer Res; 1959 Oct; 19():918-26. PubMed ID: 13801058
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammary tumor development in transplanted hyperplastic alveolar nodules of the mouse.
    BLAIR PB; DEOME KB
    Proc Soc Exp Biol Med; 1961 Nov; 108():289-91. PubMed ID: 13869741
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotinamide in adenocarcinoma 755 and in the milk of mice carrying the agent of spontaneous mammary tumor.
    ROSS V
    Experientia; 1957 Dec; 13(12):497. PubMed ID: 13512293
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative potency of the mammary tumour agent of mice of different genetic constitution.
    DMOCHOWSKI L
    Br J Exp Pathol; 1945; 26(4):267-9. PubMed ID: 21006652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the XLII strain mouse. II. Tumors of the lymphopoietic system after injections of desoxyribonucleic acid from C3H mice or an extract of a transplanted mammary tumor from that same line].
    RIVIERE MR; VENDRELY R; CHOUROULINKOV I; VENDRELY C; GUERIN M
    Bull Assoc Fr Etud Cancer; 1960; 47():254-70. PubMed ID: 13741977
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of the hydrolysis products of puromycin on mouse mammary tumors.
    OLESON JJ; BENNETT PL; HALLIDAY SL; WILLIAMS JH
    Acta Unio Int Contra Cancrum; 1955; 11(2):161-6. PubMed ID: 13248723
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity of females of the C stock to male infection with the mammary tumor agent.
    BITTNER JJ; FRANTZ MJ
    Proc Soc Exp Biol Med; 1954; 86(4):698-701. PubMed ID: 13204327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.